公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2020 | High transmissibility of COVID-19 near symptom onset | Cheng, Hao-Yuan; Jian, Shu-Wan; DING-PING LIU ; Ng, Ta-Chou; Huang, Wan-Ting; Lin, Hsien-Ho | medRxiv | | 0 | |
2022 | Increased Incidence of Adult Complicated Appendicitis in One Resource-Competent Community during the Coronavirus Disease Pandemic: Case Controlled Study (Preprint) | JIN-MING WU ; Ho, Te-Wei; HSI-YU YU ; Lai, I-Rue | JMIR Preprints | | 0 | |
2024 | Involvement of neuropeptides in pruritus of patients with bullous pemphigoid: A pilot study | YUNG-TSU CHO | Authorea | | | |
2020 | A Method to sort heterogenous cell populations based on migration in 2D and 3D environments | Arora, Aditya; Niño, Jorge Luis Galeano; Myaing, Myint Zu; Arasi, Bakya; RUBY YUN-JU HUANG ; Dasgupta, Ramanuj; Biro, Maté; Viasnoff, Virgile | bioRxiv | 0 | 0 | |
2023 | Supplementary Figure 1 from MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial | Debashis Sarker; Ruth Plummer; Tim Meyer; Mikael H. Sodergren; Bristi Basu; Cheng Ean Chee; KAI-WEN HUANG | American Association for Cancer Research | | | |
2023 | Supplementary Figure 2 from MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial | Debashis Sarker; Ruth Plummer; Tim Meyer; Mikael H. Sodergren; Bristi Basu; Cheng Ean Chee; KAI-WEN HUANG ; et al., | American Association for Cancer Research | | | |
2023 | Supplementary Figure 3 from MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial | Debashis Sarker; Ruth Plummer; Tim Meyer; Mikael H. Sodergren; Bristi Basu; Cheng Ean Chee; KAI-WEN HUANG ; et al., | American Association for Cancer Research | | | |
2023 | Supplementary Figure 4 from MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial | Debashis Sarker; Ruth Plummer; Tim Meyer; Mikael H. Sodergren; Bristi Basu; Cheng Ean Chee; KAI-WEN HUANG ; et al., | American Association for Cancer Research | | | |
2023 | Supplementary Figure 5 from MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial | Debashis Sarker; Ruth Plummer; Tim Meyer; Mikael H. Sodergren; Bristi Basu; Cheng Ean Chee; KAI-WEN HUANG ; et al., | American Association for Cancer Research | | | |
2023 | Supplementary Legends from MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial | Debashis Sarker; Ruth Plummer; Tim Meyer; Mikael H. Sodergren; Bristi Basu; Cheng Ean Chee; KAI-WEN HUANG ; et al., | American Association for Cancer Research | | | |
2023 | Supplementary Tables from MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial | Debashis Sarker; Ruth Plummer; Tim Meyer; Mikael H. Sodergren; Bristi Basu; Cheng Ean Chee; KAI-WEN HUANG ; et al., | American Association for Cancer Research | | | |